Faranak Vossoughi, MD
Hand Surgery · Katy, TXNPI 1093830689
Payments from drug & device makers
Across 58 payments — averaging $82.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sonex Health, Inc.$1K
- Medartis Inc.$972
- Arthrex$576
- Medinc Of Texas$519
- Trimed, Inc.$511
- Endo Pharmaceuticals Inc.$249
- plus $508 from 15 others
What the payments were for
- Consulting fees$54411%
- Travel & lodging$2,24047%
- Food & beverage$1,97441%
- Education$291%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sonex Health, Inc. | 11 | $1,451 |
| Medartis Inc. | 1 | $972 |
| Arthrex | 6 | $576 |
| Medinc Of Texas | 4 | $519 |
| Trimed, Inc. | 4 | $511 |
| Endo Pharmaceuticals Inc. | 11 | $249 |
| Kowa Pharmaceuticals America, Inc. | 3 | $157 |
| Acumed LLC | 2 | $55 |
| Smith+Nephew | 2 | $42 |
| Kerecis Limited | 1 | $38 |
| Bioventus LLC | 2 | $36 |
| Extremity Medical | 2 | $33 |
| Endo USA, Inc. | 1 | $21 |
| Dynasplint Systems Inc. | 1 | $21 |
| Anika Therapeutics, Inc. | 1 | $19 |
| Trice Medical, Inc. | 1 | $18 |
| Arthrosurface Incorporated | 1 | $17 |
| Aroa Biosurgery Incorporated | 1 | $17 |
| Merck | 1 | $13 |
| Amgen | 1 | $11 |
| Acell, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Sx-One Microknife$1,298
- APTUS$972
- Tools - WFS$483
- XIAFLEX$107
- Seglentis$101
How this compares
$4,787 in reported general payments places this provider in the 50th percentile of 170 hand surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylprednisolone | 12 | $182 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 19 | $114 |
| Tramadol Hcl | 17 | $45 |
| Cephalexin | 22 | $40 |
Paid to pharmacies, not to this prescriber.
Other hand surgery in Katy
- Brendan MackayLubbock$547K
- David RingAustin$536K
- John FaillaceWoodway$434K
- Kourosh JafarniaHouston$278K
- Timothy NiacarisArlington$239K
- Daniel KoehlerDallas$208K
- Steven NiedermeierArlington$169K
- William PientkaFort Worth$168K
- Ann GoldenDallas$107K
- Cameron AtkinsonArlington$103K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.